15Feb/23
Personalized Stimulation on CAR-T Cells During Manufacture Promises to Make Personalized CAR-T Cell Therapy A Reality
Since 2017, when chimeric antigen receptor-T cells (CAR-T) were approved by the US Food and Drug Administration (FDA) as the first modified cell for the treatment of leukemia, five similar products haveRead More…